Cover Image
市場調查報告書

痙攣:全球臨床實驗檢討

Spasticity Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 310009
出版日期 內容資訊 英文
訂單完成後即時交付
價格
Back to Top
痙攣:全球臨床實驗檢討 Spasticity Global Clinical Trials Review, H2, 2014
出版日期: 2014年07月31日 內容資訊: 英文
簡介

本報告提供痙攣相關的臨床研究最新趨勢分析,彙整疾病治療方法概要,及臨床實驗的主要國家──G7各國及E7(新興7國)的臨床實驗數及實驗對象採用狀況,Phase、階段別進展,有潛力的贊助商,各企業研究機關的研究進展,有潛力的藥劑比較等資訊。

目錄

簡介

  • 痙攣
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5個國家的臨床實驗數量
    • 歐洲主要5個國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東及非洲的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:中樞神經系統臨床實驗數量上,痙攣臨床實驗數量所佔的比例

G7各國臨床實驗數量:Phase別

G7各國臨床實驗數量:各進展狀況

E7各國(新興7個國家)臨床實驗數量:中樞神經系統臨床實驗數量上,痙攣臨床實驗數量所佔的比例

E7各國(新興7個國家)臨床實驗數量:Phase別

E7各國(新興7個國家)臨床實驗數量:各進展狀況

Phase別臨床實驗數量

  • 進行中的臨床實驗:Phase別

各進展狀況臨床實驗數量

試驗指標達成狀況別臨床實驗數量

尚未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商的各類型臨床實驗數量

有潛力的贊助商

有潛力的藥劑

臨床實驗簡介

  • 有代表性的企業臨床實驗概要
    • Allergan, Inc.
    • Ipsen S.A.
    • Merz Pharma GmbH & Co. KgaA
    • GW Pharmaceuticals plc
    • GlaxoSmithKline plc
    • Sun Pharma Advanced Research Company
    • MediciNova, Inc.
    • Acorda Therapeutics, Inc.
    • Concert Pharmaceuticals, Inc.
    • Almirall, S.A.
  • 有代表性的研究機關·醫院臨床實驗概要
    • Vanderbilt University
    • National Institute of Neurological Disorders and Stroke
    • University of Minnesota
    • University of Alberta
    • Eunice Kennedy Shriver National Institute of Child Health and Human Development
    • University of Manitoba
    • Princess Margaret Hospital
    • Center for Medicinal Cannabis Research
    • Department of Health, UK
    • University Hospital of Mont-Godinne

5個有代表性的臨床實驗簡介

附錄

圖表一覽

目錄
Product Code: GlobalData

GlobalData's clinical trial report, "Spasticity Global Clinical Trials Review, H2, 2014" provides data on the Spasticity clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Spasticity. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Spasticity. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Spasticity
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Spasticity to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Spasticity to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Spasticity
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Spasticity Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Allergan, Inc.
      • Clinical Trial Overview of Allergan, Inc.
      • Ipsen S.A.
      • Clinical Trial Overview of Ipsen S.A.
      • Merz Pharma GmbH & Co. KgaA
      • Clinical Trial Overview of Merz Pharma GmbH & Co. KgaA
      • GW Pharmaceuticals plc
      • Clinical Trial Overview of GW Pharmaceuticals plc
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Sun Pharma Advanced Research Company
      • Clinical Trial Overview of Sun Pharma Advanced Research Company
      • MediciNova, Inc.
      • Clinical Trial Overview of MediciNova, Inc.
      • Acorda Therapeutics, Inc.
      • Clinical Trial Overview of Acorda Therapeutics, Inc.
      • Concert Pharmaceuticals, Inc.
      • Clinical Trial Overview of Concert Pharmaceuticals, Inc.
      • Almirall, S.A.
      • Clinical Trial Overview of Almirall, S.A.
    • Clinical Trial Overview of Top Institutes / Government
      • Vanderbilt University
      • Clinical Trial Overview of Vanderbilt University
      • National Institute of Neurological Disorders and Stroke
      • Clinical Trial Overview of National Institute of Neurological Disorders and Stroke
      • University of Minnesota
      • Clinical Trial Overview of University of Minnesota
      • University of Alberta
      • Clinical Trial Overview of University of Alberta
      • Eunice Kennedy Shriver National Institute of Child Health and Human Development
      • Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development
      • University of Manitoba
      • Clinical Trial Overview of University of Manitoba
      • Princess Margaret Hospital
      • Clinical Trial Overview of Princess Margaret Hospital
      • Center for Medicinal Cannabis Research
      • Clinical Trial Overview of Center for Medicinal Cannabis Research
      • Department of Health, UK
      • Clinical Trial Overview of Department of Health, UK
      • University Hospital of Mont-Godinne
      • Clinical Trial Overview of University Hospital of Mont-Godinne
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Spasticity Therapeutics, Global, Clinical Trials by Region, 2014*
  • Spasticity Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Spasticity Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Spasticity Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Spasticity Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Spasticity Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Spasticity Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Spasticity Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Spasticity to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Spasticity Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Spasticity Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Spasticity to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Spasticity Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Spasticity Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Spasticity Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Spasticity Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Spasticity Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Spasticity Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Spasticity Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Spasticity Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Spasticity Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Spasticity Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Spasticity Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Spasticity Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Spasticity Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2014*
  • Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Ipsen S.A., 2014*
  • Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Merz Pharma GmbH & Co. KgaA, 2014*
  • Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by GW Pharmaceuticals plc, 2014*
  • Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Pharma Advanced Research Company, 2014*
  • Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by MediciNova, Inc., 2014*
  • Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Acorda Therapeutics, Inc., 2014*
  • Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Concert Pharmaceuticals, Inc., 2014*
  • Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Almirall, S.A., 2014*
  • Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2014*
  • Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014*
  • Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Minnesota, 2014*
  • Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alberta, 2014*
  • Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2014*
  • Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Manitoba, 2014*
  • Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Princess Margaret Hospital, 2014*
  • Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Center for Medicinal Cannabis Research, 2014*
  • Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, UK, 2014*
  • Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital of Mont-Godinne, 2014*

List of Figures

  • Spasticity Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Spasticity Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Spasticity Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Spasticity Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Spasticity Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Spasticity Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Spasticity Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Spasticity Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014*
  • Proportion of Spasticity to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Spasticity Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Spasticity Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Spasticity to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Spasticity Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Spasticity Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Spasticity Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Spasticity Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Spasticity Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Spasticity Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Spasticity Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Spasticity Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Spasticity Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Spasticity Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Spasticity Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top